vs
Bio-Techne（TECH）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是Bio-Techne的1.2倍（$362.7M vs $295.9M），Bio-Techne净利率更高（12.8% vs -10.7%，领先23.5%），过去两年世纪互联的营收复合增速更高（17.4% vs 4.2%）
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
TECH vs VNET — 直观对比
营收规模更大
VNET
是对方的1.2倍
$295.9M
净利率更高
TECH
高出23.5%
-10.7%
两年增速更快
VNET
近两年复合增速
4.2%
损益表 — Q2 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $295.9M | $362.7M |
| 净利润 | $38.0M | $-38.7M |
| 毛利率 | 64.6% | 20.9% |
| 营业利润率 | 18.4% | 0.5% |
| 净利率 | 12.8% | -10.7% |
| 营收同比 | -6.4% | — |
| 净利润同比 | 68.3% | — |
| 每股收益（稀释后） | $0.24 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TECHVNET
| Q4 25 | $295.9M | — | ||
| Q3 25 | — | $362.7M | ||
| Q2 25 | $317.0M | — | ||
| Q1 25 | $316.2M | $309.5M | ||
| Q4 24 | $297.0M | — | ||
| Q3 24 | $289.5M | $302.2M | ||
| Q2 24 | $306.1M | $274.4M | ||
| Q1 24 | $303.4M | $262.9M |
净利润TECHVNET
| Q4 25 | $38.0M | — | ||
| Q3 25 | — | $-38.7M | ||
| Q2 25 | $-17.7M | — | ||
| Q1 25 | $22.6M | $-2.4M | ||
| Q4 24 | $34.9M | — | ||
| Q3 24 | $33.6M | $-2.1M | ||
| Q2 24 | $40.6M | $-1.1M | ||
| Q1 24 | $49.1M | $-22.0M |
毛利率TECHVNET
| Q4 25 | 64.6% | — | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | 62.7% | — | ||
| Q1 25 | 67.9% | 25.2% | ||
| Q4 24 | 65.3% | — | ||
| Q3 24 | 63.2% | 23.2% | ||
| Q2 24 | 66.4% | 21.3% | ||
| Q1 24 | 67.4% | 21.6% |
营业利润率TECHVNET
| Q4 25 | 18.4% | — | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | -7.5% | — | ||
| Q1 25 | 12.2% | 0.1% | ||
| Q4 24 | 16.0% | — | ||
| Q3 24 | 13.8% | 24.5% | ||
| Q2 24 | 15.0% | 0.2% | ||
| Q1 24 | 22.1% | 0.2% |
净利率TECHVNET
| Q4 25 | 12.8% | — | ||
| Q3 25 | — | -10.7% | ||
| Q2 25 | -5.6% | — | ||
| Q1 25 | 7.1% | -0.8% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 11.6% | -0.7% | ||
| Q2 24 | 13.3% | -0.4% | ||
| Q1 24 | 16.2% | -8.4% |
每股收益（稀释后）TECHVNET
| Q4 25 | $0.24 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.21 | — | ||
| Q2 24 | $0.26 | — | ||
| Q1 24 | $0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $172.9M | $492.1M |
| 总债务越低越好 | $260.0M | — |
| 股东权益账面价值 | $2.0B | $890.8M |
| 总资产 | $2.5B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.13× | — |
8季度趋势，按日历期对齐
现金及短期投资TECHVNET
| Q4 25 | $172.9M | — | ||
| Q3 25 | — | $492.1M | ||
| Q2 25 | $162.2M | — | ||
| Q1 25 | $140.7M | $544.3M | ||
| Q4 24 | $177.5M | — | ||
| Q3 24 | $187.5M | $219.5M | ||
| Q2 24 | $152.9M | $247.2M | ||
| Q1 24 | $145.3M | $246.9M |
总债务TECHVNET
| Q4 25 | $260.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $346.0M | — | ||
| Q1 25 | $330.0M | — | ||
| Q4 24 | $300.0M | — | ||
| Q3 24 | $300.0M | $1.2B | ||
| Q2 24 | $319.0M | — | ||
| Q1 24 | $389.0M | — |
股东权益TECHVNET
| Q4 25 | $2.0B | — | ||
| Q3 25 | — | $890.8M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $2.0B | $927.8M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $902.9M | ||
| Q2 24 | $2.1B | $900.6M | ||
| Q1 24 | $2.0B | $895.1M |
总资产TECHVNET
| Q4 25 | $2.5B | — | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | $5.4B | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.7B | $4.3B | ||
| Q2 24 | $2.7B | $4.0B | ||
| Q1 24 | $2.7B | $3.9B |
负债/权益比TECHVNET
| Q4 25 | 0.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | 1.28× | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $113.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-193.1M |
| 自由现金流率自由现金流/营收 | — | -53.2% |
| 资本支出强度资本支出/营收 | — | 84.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-589.7M |
8季度趋势，按日历期对齐
经营现金流TECHVNET
| Q4 25 | — | — | ||
| Q3 25 | — | $113.8M | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $41.1M | $27.0M | ||
| Q4 24 | $84.3M | — | ||
| Q3 24 | $63.9M | $108.3M | ||
| Q2 24 | $75.5M | $55.8M | ||
| Q1 24 | $81.0M | $37.1M |
自由现金流TECHVNET
| Q4 25 | — | — | ||
| Q3 25 | — | $-193.1M | ||
| Q2 25 | $93.3M | — | ||
| Q1 25 | $31.0M | $-220.0M | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $54.7M | $-95.0M | ||
| Q2 24 | $57.5M | $-81.6M | ||
| Q1 24 | $64.5M | $-102.2M |
自由现金流率TECHVNET
| Q4 25 | — | — | ||
| Q3 25 | — | -53.2% | ||
| Q2 25 | 29.4% | — | ||
| Q1 25 | 9.8% | -71.1% | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 18.9% | -31.4% | ||
| Q2 24 | 18.8% | -29.8% | ||
| Q1 24 | 21.3% | -38.9% |
资本支出强度TECHVNET
| Q4 25 | — | — | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 3.2% | 79.8% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 3.2% | 67.3% | ||
| Q2 24 | 5.9% | 50.1% | ||
| Q1 24 | 5.4% | 53.0% |
现金转化率TECHVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 2.42× | — | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
VNET
暂无分部数据
